MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Example Regimen Definition: ddAC→T (Dose-Dense AC then Paclitaxel) (Experimental)

Official URL: http://hl7.org/fhir/us/codex-mopa/PlanDefinition/RegimenDdACT Version: 0.1.1-snapshot-080926
Standards status: Informative Computable Name: RegimenDdACT

Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer.

Metadata
Title ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer
Version 0.1.1-snapshot-080926
Experimental true
Subject Type Malignant neoplasm of breast
Jurisdiction United States of America
Steward (Publisher) HL7 International / Clinical Interoperability Council
Steward Contact HL7 International / Clinical Interoperability Council
Description

Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer.
Type Order Set
PlanDefinition Action
Id ac-phase
Title AC Phase — Doxorubicin + Cyclophosphamide (q14d × 4 cycles)
Timing Count 4 times, Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id doxorubicin-ac
Title Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id doxorubicin-ac
Title Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id pegfilgrastim-ac
Title Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle
Description Pegfilgrastim supportive care on day 2 of each ddAC cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id pegfilgrastim-ac
Title Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle
Description Pegfilgrastim supportive care on day 2 of each ddAC cycle
Timing Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id cyclophosphamide-ac
Title Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id cyclophosphamide-ac
Title Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Action
Id t-phase
Title T Phase — Paclitaxel (q14d × 4 cycles)
Timing Count 4 times, Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: t-phase)
Id paclitaxel-t
Title Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id paclitaxel-t
Title Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
Generated using version 0.5.4 of the sample-content-ig Liquid templates